Patents by Inventor Francis Moore
Francis Moore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230080444Abstract: A device for treatment of cells with particles is disclosed. The device includes a semi-permeable membrane positioned between two plates, the first plate defining a first flow chamber and comprising a port, a flow channel, a transverse port, and a transverse flow channel, the first flow chamber constructed and arranged to deliver fluid in a transverse direction along the first side of the semi-permeable membrane, the second plate defining a second flow chamber and comprising a port. A method for transducing cells is disclosed. The method includes introducing a fluid with cells and viral particles into a flow chamber adjacent a semi-permeable membrane such that the cells and the viral particles are substantially evenly distributed on the semi-permeable membrane. The method also includes introducing a recovery fluid to suspend the cells and the viral particles, and separating the cells from the viral particles. A method of activating cells is disclosed.Type: ApplicationFiled: September 16, 2022Publication date: March 16, 2023Inventors: Kenneth T. Kotz, Bryan D. Teece, James Gillett Truslow, Nathan Francis Moore, Jeffrey T. Borenstein, Vishal Tandon
-
Publication number: 20230063282Abstract: A device for treatment of cells with particles is disclosed. The device includes a semi-permeable membrane positioned between two plates, the first plate defining a first flow chamber and comprising a port, a flow channel, a transverse port, and a transverse flow channel, the first flow chamber constructed and arranged to deliver fluid in a transverse direction along the first side of the semi-permeable membrane, the second plate defining a second flow chamber and comprising a port. A method for transducing cells is disclosed. The method includes introducing a fluid with cells and viral particles into a flow chamber adjacent a semi-permeable membrane such that the cells and the viral particles are substantially evenly distributed on the semi-permeable membrane. The method also includes introducing a recovery fluid to suspend the cells and the viral particles, and separating the cells from the viral particles. A method of activating cells is disclosed.Type: ApplicationFiled: September 16, 2022Publication date: March 2, 2023Applicant: THE CHARLES STARK DRAPER LABORATORY, INC.Inventors: Kenneth T. Kotz, Bryan D. Teece, James Gillett Truslow, Nathan Francis Moore, Jeffrey T. Borenstein, Vishal Tandon
-
Patent number: 11584908Abstract: A device for treatment of cells with particles is disclosed. The device includes a semi-permeable membrane positioned between two plates, the first plate defining a first flow chamber and comprising a port, a flow channel, a transverse port, and a transverse flow channel, the first flow chamber constructed and arranged to deliver fluid in a transverse direction along the first side of the semi-permeable membrane, the second plate defining a second flow chamber and comprising a port. A method for transducing cells is disclosed. The method includes introducing a fluid with cells and viral particles into a flow chamber adjacent a semi-permeable membrane such that the cells and the viral particles are substantially evenly distributed on the semi-permeable membrane. The method also includes introducing a recovery fluid to suspend the cells and the viral particles, and separating the cells from the viral particles. A method of activating cells is disclosed.Type: GrantFiled: September 20, 2018Date of Patent: February 21, 2023Assignee: THE CHARLES STARK DRAPER LABORATORY, INC.Inventors: Kenneth T. Kotz, Bryan D. Teece, James Gillett Truslow, Nathan Francis Moore, Jeffrey T. Borenstein, Vishal Tandon
-
Publication number: 20220380480Abstract: The present invention relates to the treatment of subjects having CD20-positive cell proliferative disorders (e.g., B cell proliferative disorders, such as non-Hodgkin's lymphomas). More specifically, the invention pertains to the treatment of subjects having a CD20-positive cell proliferative disorder (e.g., B cell proliferative disorder) by administering a combination of an anti-CD20/anti-CD3 bispecific antibody and an anti-CD79b antibody drug conjugate.Type: ApplicationFiled: April 29, 2022Publication date: December 1, 2022Applicant: Hoffmann-La Roche Inc.Inventors: Katharina LECHNER, Thomas Francis MOORE, Martin WEISSER, Natalie DIMIER
-
Publication number: 20220372156Abstract: The present invention relates to methods of treating a B-cell proliferative disorder by administering an anti-CD20/anti-CD3 bispecific antibody, and methods for reduction of adverse effects in response to the administration of the anti-CD20/anti-CD3 bispecific antibody. The present invention further relates to combination treatment methods of treating a B-cell proliferative disorder.Type: ApplicationFiled: April 29, 2022Publication date: November 24, 2022Applicants: Hoffmann-La Roche Inc., Roche TCRC Inc.Inventors: Katharina LECHNER, Linda LUNDBERG, Thomas Francis MOORE, Peter MORCOS, Martin WEISSER, Marina BACAC, Martin BARRETT, Axel BOEHNKE, David CARLILE, Nassim DJEBLI
-
Patent number: 11291756Abstract: A method for separating cells in a biofluid includes pretreating the biofluid by introducing an additive comprising a cell activator, flowing the pretreated biofluid through a microfluidic separation channel, and applying acoustic energy to the microfluidic separation channel to accumulate target cells in a primary stream and non-target cells in a secondary stream. A system for microfluidic cell separation capable of separating target cells from non-target cells in a biofluid includes at least one microfluidic separation channel, a source of biofluid, a source of additive comprising a cell activator, and at least one acoustic transducer coupled to the microfluidic separation channel.Type: GrantFiled: June 25, 2019Date of Patent: April 5, 2022Assignee: THE CHARLES STARK DRAPER LABORATORY, INC.Inventors: Jason O. Fiering, Kenneth T. Kotz, Nathan Francis Moore
-
Publication number: 20190307946Abstract: A method for separating cells in a biofluid includes pretreating the biofluid by introducing an additive comprising a cell activator, flowing the pretreated biofluid through a microfluidic separation channel, and applying acoustic energy to the microfluidic separation channel to accumulate target cells in a primary stream and non-target cells in a secondary stream. A system for microfluidic cell separation capable of separating target cells from non-target cells in a biofluid includes at least one microfluidic separation channel, a source of biofluid, a source of additive comprising a cell activator, and at least one acoustic transducer coupled to the microfluidic separation channel.Type: ApplicationFiled: June 25, 2019Publication date: October 10, 2019Inventors: Jason O. Fiering, Kenneth T. Kotz, Nathan Francis Moore
-
Publication number: 20190085280Abstract: A device for treatment of cells with particles is disclosed. The device includes a semi-permeable membrane positioned between two plates, the first plate defining a first flow chamber and comprising a port, a flow channel, a transverse port, and a transverse flow channel, the first flow chamber constructed and arranged to deliver fluid in a transverse direction along the first side of the semi-permeable membrane, the second plate defining a second flow chamber and comprising a port. A method for transducing cells is disclosed. The method includes introducing a fluid with cells and viral particles into a flow chamber adjacent a semi-permeable membrane such that the cells and the viral particles are substantially evenly distributed on the semi-permeable membrane. The method also includes introducing a recovery fluid to suspend the cells and the viral particles, and separating the cells from the viral particles. A method of activating cells is disclosed.Type: ApplicationFiled: September 20, 2018Publication date: March 21, 2019Inventors: Kenneth T. Kotz, Bryan D. Teece, James Gillett Truslow, Nathan Francis Moore
-
Patent number: 7752071Abstract: A process and system for generating a job value for a job that can be used to provide a definitive measure of contribution of the job to an entity. The process involves generating an impact value representing effect of the job on an entity, generating an input value representing attributes of the job, and generating the job value on the basis of the impact value and the input value. The impact value is determined on the basis of an accountability value and a job type value. The accountability value represents results expected from the job by the entity, and the type value represents the significance of the job to the entity. The input value is determined on the basis of a knowledge value, and an integration value, and an interpersonal value. The knowledge value represents the level of knowledge required to perform the job. The integration value represents the level the job requires the coordination, integration and direction of resources.Type: GrantFiled: August 5, 2002Date of Patent: July 6, 2010Assignee: Aequus Consulting Pty LtdInventors: James Walter Anson, William Francis Moore
-
Patent number: 7445703Abstract: A water conductivity monitoring circuit determines the status of an ion exchange filter in the water flow to a steam generator. A microprocessor sends a reference signal to a conductivity sensor circuit that converts it to an excite signal that is sent to a probe in the water flow. Any conductivity of the water alters the excite signal, and the modified signal is compared to the reference signal to establish a value indicative of the conductivity of the water. The microprocessor compares the value to at least two thresholds representative of the status of the filter.Type: GrantFiled: March 1, 2006Date of Patent: November 4, 2008Assignee: Whirlpool CorporationInventors: Jason Randall Savage, Dwain Francis Moore, Thomas N. Robinson, Joel Matthew Sells
-
Publication number: 20050276811Abstract: The invention provides natural IgM antibody inhibitors that may be used to treat various inflammatory diseases or disorders.Type: ApplicationFiled: March 1, 2005Publication date: December 15, 2005Inventors: Michael Carroll, Francis Moore, Herbert Hechtman
-
Publication number: 20050029158Abstract: A package adapted to contain a hard copy consumable, the package comprising a protection element, the element being connected to the package and having a surface adapted to be removably connected to a portion of the consumable, such that the element is arranged to be removed from the portion of the consumable by the action of removing the consumable from the package.Type: ApplicationFiled: July 30, 2003Publication date: February 10, 2005Inventors: Francis Moore, Ronan Diviney, Paul Keyes